Category survey

Identification of prediction and progression biomarkers in the earliest stages of Parkinson’s disease Investments > €500k Germany Parkinson’s disease & PD-related disorders 2016    

Role of APP for brain physiology and therapy of Alzheimer ‘s disease – analysis of APP / APLP mediated effects on neuronal morphology and function of the hippocampus Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Optimization of P2X4 receptor antagonists as therapeutics for neurodegenerative and neuroinflammatory diseases Investments > €500k Germany Neurodegenerative disease in general 2016    

European network to optimize the care of patients with amyotrophic lateral sclerosis (ALS) and their relatives Investments > €500k Germany Motor neurone diseases 2016    

Development of a novel Alzheimers test based on a microfluidic chip for the analysis of erythrocyte markers Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

EmoRobot – Emotions stimulating assisting robots in the care and support of people suffering from dementia in long-term care Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Identification and characterization of Novel drug targets in neurodegenerative diseases by RNAi screening Investments > €500k Germany Neurodegenerative disease in general 2016    

Contributions to the basic understanding of pathological protein processing and toxicity in Machado-Joseph disease Investments > €500k Germany Spinocerebellar ataxia (SCA) 2016    

New ways to support family members – e-learning and counseling on dementia Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Prenatal, predictive and presymptomatic diagnosis of neurodegenerative diseases – ethical analysis Investments > €500k Germany Neurodegenerative disease in general 2016    

Development and dissemination of a web-based support for people with dementing dementia and their loved ones Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Implementation of a work aid for the recognition and satisfaction of the needs of people with severe dementia in the care outpatient and inpatient care of elderly people with the aim of a needs-oriented care Investments > €500k Germany Alzheimer’s…

The role of the complement system in the brain Investments > €500k Hungary Neurodegenerative disease in general|Parkinson’s disease & PD-related disorders 2016    

Integrated genomic and biochemical studies to understand the molecular mechanisms of neurodegenerative disease and the development of new therapeutics Investments > €500k Hungary Neurodegenerative disease in general|Parkinson’s disease & PD-related disorders 2016    

Development of new pharmaceutical drugs to treat dementia Investments > €500k Hungary Alzheimer’s disease & other dementias|Neurodegenerative disease in general 2016    

Preparation of iPs cells for modeling of neurological disorders Investments > €500k Hungary Neurodegenerative disease in general 2016    

Non-classic functions of estrogen Investments > €500k Hungary Alzheimer’s disease & other dementias|Neurodegenerative disease in general 2016    

PET ligands as in vivo diagnostic agents for neuroinflammatory, neurodegenerative and neuro-oncological diseases Investments > €500k Germany Neurodegenerative disease in general 2016    

Care coaching for the optimal support of people with dementia Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Securing intersectoral care through an IT-based service concept for multimorbid patients with dementia Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Understanding challenging behavior – the individual-situative technical support for dementia Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Metabolic imaging in neurodegenerative diseases Investments > €500k Germany Neurodegenerative disease in general 2016    

Mobilization assistant for patients with dementia and their relatives Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Fluorescence microscopy and therapy monitoring of Alzheimer’s disease and other tauopathies in the olfactory mucosa Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Music systems for the therapy and activation of dementia patients Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Interactive safety and assistance system to increase the safety and participation of persons with dementia Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Competition “Local alliances for people with dementia” 2014 Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Individual activation of people with dementia Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

201TlDDC-SPECT for early diagnosis of dementia Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Personal life documentation for people with dementia and caregivers Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Smart emergency chain in the quarter as a back-up structure for people with dementia Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Competence Network Dementia – rpAD Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Virtual assistant to support people with MCI based on Smart Glasses Investments > €500k Germany Neurodegenerative disease in general 2016    

Epigenomics of Parkinson’s Disease – Functional Analysis Investments > €500k Germany Parkinson’s disease & PD-related disorders 2016    

Characterization of modified amyloid peptides for the derivation of vaccine strategies and specific detection methods Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Development of new therapies for the treatment of Alzheimer’s disease and / or multiple sclerosis by modulation of oxidative stress in combination with new selective inhibitors Investments > €500k Germany Alzheimer’s disease & other dementias 2016    

Nanotubes to overcome the blood-brain barrier for the therapy of neurodegenerative diseases and to construct a microfluidic barrier model Investments > €500k Germany Neurodegenerative disease in general 2016    

Etude longitudinale en imagerie multimodale de la maladie d’Alzheimer à un stade précoce : biomarqueurs de détection et de progression et mécanismes physiopathologiques. Longitudinal study in multimodal imaging of Alzheimer’s disease at an early stage: biomarkers for detection and progression…

Etude des facteurs prédictifs de la réponse thérapeutique sur la qualité de vie de la stimulation subthalamique dans la Maladie de Parkinson. Study of predictive factors of therapeutic response on the quality of life of subthalamic stimulation in Parkinson’s disease…

Co-LEsions dans la Maladie d’Alzheimer et les maladies apparentées. Co-lesions in Alzheimer’s Disease and Related Diseases Investments > €500k France Alzheimer’s disease & other dementias 2016    

Etude de phase IIa dans la maladie de Huntington visant à évaluer le potentiel thérapeutique du resvératrol. Phase IIa study in Huntington disease to evaluate the therapeutic potential of resveratrol Investments > €500k France Huntington’s disease 2016    

Evaluation des effets antalgiques de l’OXYcodone LP et de la L-Dopa, versus placebo, dans les DOuleurs neuropathiques centrales du patient PArkinsonien : Essai OXYDOPA. Evaluation of the analgesic effects of OXYcodone LP and L-Dopa, versus placebo, in the central neuropathic…

Impact neuroprotecteur, moteur et cognitif du travail aérobie prolongé à haute intensité dans la maladie de Parkinson. Comparaison de deux programmes de réentraînement à l’effort d’intensités différentes et d’un programme de kinésithérapie conventionnelle appliqués pendant 9 mois. Neuroprotective, motor and…

Prédire pour prévenir les démences frontotemporales (DFT) et la sclérose latérale amyotrophique (SLA). Predict to prevent frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) Investments > €500k France Motor neurone diseases 2016    

Etude de l’efficacité de la pimavaserin sur les troubles du contrôle des impulsions dans la maladie de Parkinson. Study of the efficacy of pimavaserin on impulse control disorders in Parkinson’s disease. Investments > €500k France Parkinson’s disease & PD-related disorders…

Étude de l’efficacité de la Pompe à Apomorphine dans la maladie de Parkinson au stade précoce de la maladie. Study of the efficacy of the Apomorphine Pump in Parkinson’s Disease Early Stage Investments > €500k France Parkinson’s disease & PD-related…

AMP-activated protein kinase in the pathogenesis of Alzheimer’s disease Investments > €500k France Alzheimer’s disease & other dementias 2016    

Institutional Funding through Helmholtz Programme Oriented Funding (POF) Investments > €500k Germany Alzheimer’s disease & other dementias|Neurodegenerative disease in general|Parkinson’s disease & PD-related disorders 2016    

Institutional Funding through Helmholtz Programme Oriented Funding (POF) Investments > €500k Germany Alzheimer’s disease & other dementias|Neurodegenerative disease in general|Parkinson’s disease & PD-related disorders 2016    

New concept for the treatment of neuroinflammatory and neurodegenerative diseases Investments > €500k Germany Neurodegenerative disease in general 2016